Schizophrenia, Schizoaffective Disorder Clinical Trial
Official title:
Randomized Controlled Trial of Computerized Cognitive Behavioral Therapy for Auditory Hallucinations in Persons With Psychosis
This is a randomized controlled trial, examining the effects of a computerized, internet-based Cognitive Behavioral Therapy (CBT) Intervention for persons with a schizophrenia spectrum disorder who experience distressing auditory hallucinations (voices). Participants are randomized to one of two conditions: either to receive the 10-session computer-based program on a weekly basis, or to their usual care at their mental health clinic. This study takes place at Cambridge Health Alliance in Cambridge Massachusetts. It is hypothesized that the participants who participate in the CBT program will have significant improvements in the severity of their auditory hallucinations, as well as their associated distress, compared to the participants receiving usual care.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04512066 -
A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
|
Phase 2 | |
| Completed |
NCT00224315 -
Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial
|
Phase 4 | |
| Recruiting |
NCT02808533 -
Topiramate and Schizophrenia: Effects on Weight and Psychopathology
|
N/A | |
| Recruiting |
NCT06319170 -
Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder
|
Phase 1 | |
| Terminated |
NCT03669640 -
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
|
Phase 2 |